Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,216 | 21 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $605.80 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $360.46 | 3 | $0 (2023) |
| Fresenius USA Marketing, Inc. | $242.90 | 2 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $241.99 | 2 | $0 (2024) |
| GENZYME CORPORATION | $209.08 | 2 | $0 (2024) |
| Horizon Therapeutics plc | $179.19 | 2 | $0 (2023) |
| CALLIDITAS THERAPEUTICS US INC. | $119.00 | 1 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $117.10 | 1 | $0 (2023) |
| Medtronic, Inc. | $106.88 | 1 | $0 (2022) |
| NXSTAGE MEDICAL, INC. | $33.49 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,118 | 11 | AstraZeneca Pharmaceuticals LP ($484.08) |
| 2023 | $751.67 | 7 | Horizon Therapeutics plc ($179.19) |
| 2022 | $106.88 | 1 | Medtronic, Inc. ($106.88) |
| 2019 | $239.20 | 2 | GlaxoSmithKline, LLC. ($239.20) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $105.21 | General |
| 10/18/2024 | NXSTAGE MEDICAL, INC. | NXSTAGE SYSTEM ONE (Device), LIBERTY SELECT CYCLER | Food and Beverage | In-kind items and services | $33.49 | General |
| Category: Nephrology | ||||||
| 10/10/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $117.91 | General |
| Category: Phosphate binder for ESRD | ||||||
| 09/28/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $86.48 | General |
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $121.98 | General |
| 09/04/2024 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $117.10 | General |
| Category: Hematology | ||||||
| 05/22/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $47.77 | General |
| 03/14/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $121.57 | General |
| Category: Rare Disease | ||||||
| 03/13/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Phosphate binder for ESRD | ||||||
| 01/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $122.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/18/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $119.00 | General |
| Category: Nephrology | ||||||
| 12/05/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $49.74 | General |
| Category: KRYSTEXXA | ||||||
| 10/06/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $117.10 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/10/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $129.45 | General |
| Category: KRYSTEXXA | ||||||
| 07/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $121.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/28/2023 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $91.98 | General |
| Category: Hematology | ||||||
| 04/06/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $120.42 | General |
| Category: Rare Disease | ||||||
| 02/01/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $121.26 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2022 | Medtronic, Inc. | INVOS (Device) | Food and Beverage | In-kind items and services | $106.88 | General |
| Category: Cerebral/Somatic Oximetry | ||||||
| 10/30/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $114.21 | General |
| Category: IMMUNOLOGY | ||||||
| 05/16/2019 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 73 | 95 | $23,541 | $9,724 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $8,800 | $3,499 | 39.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 30 | $7,089 | $3,159 | 44.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 29 | $4,501 | $1,890 | 42.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $3,151 | $1,177 | 37.3% |
About Dr. Jennifer Pham, MD
Dr. Jennifer Pham, MD is a Nephrology healthcare provider based in Chula Vista, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2018. The National Provider Identifier (NPI) number assigned to this provider is 1235629932.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jennifer Pham, MD has received a total of $2,216 in payments from pharmaceutical and medical device companies, with $1,118 received in 2024. These payments were reported across 21 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($2,216).
As a Medicare-enrolled provider, Pham has provided services to 73 Medicare beneficiaries, totaling 95 services with total Medicare billing of $9,724. Data is available for 1 year (2023–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Chula Vista, CA
- Active Since 05/17/2018
- Last Updated 01/16/2026
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1235629932
Products in Payments
- FARXIGA (Drug) $244.36
- Velphoro (Drug) $242.90
- ULTOMIRIS (Biological) $241.99
- CABLIVI (Biological) $209.08
- KRYSTEXXA (Biological) $179.19
- ANORO ELLIPTA (Drug) $124.99
- BENLYSTA (Biological) $121.26
- TARPEYO (Drug) $119.00
- LUPKYNIS (Drug) $117.10
- NUCALA (Biological) $114.21
- INVOS (Device) $106.88
- NXSTAGE SYSTEM ONE (Device) $33.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Chula Vista
John Videen, Md, MD
Nephrology — Payments: $42,026
Jill Meyer, Md, MD
Nephrology — Payments: $12,736
Dr. Diogo Belo, M.d, M.D
Nephrology — Payments: $10,080
Rodrigo Fernandez, Md, MD
Nephrology — Payments: $9,733
Dr. Ricardo Soltero, M.d, M.D
Nephrology — Payments: $5,174
Adam Horeish, Md, MD
Nephrology — Payments: $5,107